X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3561) 3561
Book Review (974) 974
Publication (286) 286
Newsletter (97) 97
Book / eBook (49) 49
Newspaper Article (47) 47
Book Chapter (32) 32
Conference Proceeding (10) 10
Magazine Article (4) 4
Dissertation (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3044) 3044
humans (2256) 2256
diabetes (1809) 1809
male (1657) 1657
female (1243) 1243
animals (1164) 1164
endocrinology & metabolism (949) 949
middle aged (893) 893
risk factors (860) 860
diabetes mellitus (820) 820
cardiac & cardiovascular systems (795) 795
cardiomyopathy (774) 774
mortality (770) 770
diabetics (747) 747
oxidative stress (703) 703
aged (682) 682
diabetic cardiomyopathy (672) 672
type 2 diabetes (589) 589
heart (574) 574
cardiovascular disease (555) 555
heart failure (546) 546
rats (539) 539
diabetes mellitus, type 2 - complications (535) 535
mellitus (508) 508
heart diseases (503) 503
glucose (476) 476
adult (464) 464
care and treatment (457) 457
hypertension (453) 453
analysis (435) 435
research (435) 435
health aspects (428) 428
cardiology (375) 375
heart-failure (364) 364
hyperglycemia (364) 364
mice (358) 358
rodents (347) 347
cardiovascular diseases (341) 341
apoptosis (335) 335
medicine & public health (321) 321
disease (320) 320
abridged index medicus (319) 319
insulin (316) 316
risk (304) 304
pharmacology & pharmacy (292) 292
physiological aspects (286) 286
echocardiography (285) 285
proteins (284) 284
complications (282) 282
medicine, research & experimental (276) 276
prevalence (276) 276
myocardium - metabolism (274) 274
insulin resistance (273) 273
dysfunction (272) 272
complications and side effects (271) 271
prognosis (270) 270
diabetic cardiomyopathies - physiopathology (268) 268
insulin-resistance (266) 266
cardiovascular-disease (264) 264
medical research (259) 259
inflammation (254) 254
myocardial-infarction (254) 254
cell biology (251) 251
metabolism (251) 251
fibrosis (247) 247
studies (247) 247
blood pressure (244) 244
diabetes mellitus, type 2 - drug therapy (241) 241
heart attacks (239) 239
diabetes mellitus, type 2 - physiopathology (238) 238
physiology (237) 237
internal medicine (236) 236
cardiovascular (235) 235
dextrose (228) 228
diabetic cardiomyopathies - metabolism (227) 227
blood glucose - metabolism (226) 226
myocardium - pathology (226) 226
hypoglycemic agents - therapeutic use (220) 220
medicine (217) 217
diabetic angiopathies - physiopathology (210) 210
diabetic cardiomyopathies - prevention & control (209) 209
medicine, experimental (199) 199
biochemistry & molecular biology (196) 196
disease models, animal (196) 196
treatment outcome (196) 196
coronary heart disease (194) 194
diabetic angiopathies - epidemiology (193) 193
atherosclerosis (192) 192
diastolic dysfunction (192) 192
expression (189) 189
streptozocin (189) 189
association (188) 188
follow-up studies (187) 187
rats, sprague-dawley (187) 187
diabetic cardiomyopathies - epidemiology (184) 184
diabetes mellitus, type 2 - blood (183) 183
research article (183) 183
diabetes mellitus, type 1 - complications (182) 182
time factors (182) 182
patients (180) 180
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Credit Valley Hospital - Stacks (2) 2
Online Resources - Online (2) 2
Providence Healthcare - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3756) 3756
German (12) 12
French (7) 7
Spanish (6) 6
Polish (3) 3
Portuguese (2) 2
Chinese (1) 1
Croatian (1) 1
Czech (1) 1
Italian (1) 1
Japanese (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes obesity & metabolism, ISSN 1462-8902, 07/2017, Volume 19, Issue 7, pp. 926 - 935
Two large cardiovascular outcome trials of canagliflozin, comprising the CANVAS Program, will complete in early 2017: the CANagliflozin cardioVascular... 
cardiovascular disease | type 2 diabetes | inhibitor | SGLT2 | SGLT2 inhibitor | DESIGN | EVENTS | EFFICACY | SAFETY | RATIONALE | CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT | CONJUNCTION | BASE-LINE CHARACTERISTICS | ENDOCRINOLOGY & METABOLISM | PLACEBO-CONTROLLED TRIAL | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Dose-Response Relationship, Drug | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Equivalence Trials as Topic | Diabetes Mellitus, Type 2 - complications | Canagliflozin - administration & dosage | Hypoglycemic Agents - therapeutic use | Reproducibility of Results | Double-Blind Method | Sodium-Glucose Transporter 2 - metabolism | Mortality | Risk Factors | Diabetic Angiopathies - mortality | Biomarkers - blood | Canagliflozin - adverse effects | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - mortality | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Hypoglycemic Agents - adverse effects | Cohort Studies | Type 2 diabetes | Index Medicus | Clinical Trial Design
Journal Article
Diabetic Medicine, ISSN 0742-3071, 01/2017, Volume 34, Issue 1, pp. 56 - 63
This nationwide, population‐based study is a long‐term follow‐up of two cohorts, diagnosed with childhood‐onset Type 1 diabetes in 1973–1982 and 1989–2012... 
ALL-CAUSE MORTALITY | POPULATION | EXCESS MORTALITY | CAUSE-SPECIFIC MORTALITY | NORWAY | ENDOCRINOLOGY & METABOLISM | NATIONWIDE COHORT | TRENDS | NEPHROPATHY | ASSOCIATION | CHILDREN | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Child, Preschool | Infant | Male | Diabetes Complications - diagnosis | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - therapy | Diabetic Cardiomyopathies - physiopathology | Cardiovascular Diseases - complications | Diabetic Angiopathies - physiopathology | Mortality, Premature - ethnology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Female | Registries | Retrospective Studies | Diabetic Angiopathies - prevention & control | Child | Diabetes Complications - prevention & control | Severity of Illness Index | Cardiovascular Diseases - physiopathology | Diabetes Complications - physiopathology | Diabetic Angiopathies - mortality | Combined Modality Therapy | Diabetic Cardiomyopathies - diagnosis | Diabetes Complications - mortality | Diabetes Mellitus, Type 1 - mortality | Diabetes Mellitus, Type 1 - diagnosis | Norway - epidemiology | Adolescent | Age of Onset | Sex Factors | Diabetic Angiopathies - diagnosis | Cohort Studies | Children | Type 1 diabetes | Health aspects | Mortality | Cardiovascular disease | Diabetes | Health risk assessment | Age | Index Medicus
Journal Article
Journal Article
Diabetic Medicine, ISSN 0742-3071, 07/2017, Volume 34, Issue 7, pp. 946 - 957
The Darwin Region Urban Indigenous Diabetes (DRUID) follow‐up study is one of the few studies to assess the prospective associations of diabetes and... 
GLOMERULAR-FILTRATION-RATE | ALL-CAUSE | HYPERGLYCEMIA | MYOCARDIAL-INFARCTION | PREDICTORS | GLUCOSE | ENDOCRINOLOGY & METABOLISM | POPULATIONS | CORONARY-HEART-DISEASE | INDIANS | BURDEN | Diabetic Cardiomyopathies - ethnology | Prevalence | Prospective Studies | Cardiovascular Diseases - ethnology | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Humans | Male | Renal Insufficiency, Chronic - complications | Incidence | Cardiovascular Diseases - complications | Diabetic Nephropathies - physiopathology | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Renal Insufficiency, Chronic - mortality | Adult | Diabetic Angiopathies - complications | Female | Oceanic Ancestry Group | Albuminuria - etiology | Mortality | Risk Factors | Diabetic Angiopathies - mortality | Proportional Hazards Models | Albuminuria - ethnology | Diabetic Cardiomyopathies - complications | Diabetic Angiopathies - ethnology | Diabetic Nephropathies - ethnology | Renal Insufficiency, Chronic - physiopathology | Australia - epidemiology | Diabetic Nephropathies - mortality | Diabetic Nephropathies - complications | Health Surveys | Renal Insufficiency, Chronic - ethnology | Diabetic Cardiomyopathies - epidemiology | Adolescent | Urban Health - ethnology | Diabetic Angiopathies - epidemiology | Aged | Cohort Studies | Hypertension | Medical research | Medicine, Experimental | Australian aborigines | Health aspects | Glucose tolerance tests | Risk factors | Risk groups | Diabetes mellitus | Cardiovascular disease | Population studies | Glucose tolerance | Population | Diabetes | Cardiovascular diseases | Health risk assessment | Public health | Smoking | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2015, Volume 17, Issue 4, pp. 350 - 362
Aims: To evaluate the association between insulin exposure and all-cause mortality, incident major adverse cardiovascular events (MACE) and incident cancer in... 
epidemiology | dose | type 2 diabetes | insulin | all‐cause mortality | cancer | major adverse cardiovascular events | Type 2 diabetes | All-cause mortality | Major adverse cardiovascular events | Dose | Epidemiology | Insulin | Cancer | ARRHYTHMIAS | METAANALYSIS | FOLLOW-UP | RISK | MELLITUS | all-cause mortality | DISEASE | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | RESISTANCE | THERAPIES | OUTCOMES | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Incidence | Dose-Response Relationship, Drug | Neoplasms - complications | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Female | Retrospective Studies | Diabetic Angiopathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Mortality | Diabetic Angiopathies - mortality | Proportional Hazards Models | Neoplasms - mortality | Insulin - administration & dosage | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - mortality | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Electronic Health Records | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | United Kingdom - epidemiology | Insulin - therapeutic use | Neoplasms - epidemiology | Cohort Studies | Analysis | Glucose | Health aspects | Dextrose | Confidence intervals | Diabetes | Health risk assessment | Index Medicus
Journal Article
DIABETIC MEDICINE, ISSN 0742-3071, 03/2017, Volume 34, Issue 3, pp. 372 - 379
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 1903 - 1910
Aims Patients with type 2 diabetes have a high risk of cardiovascular disease (CVD). Central obesity has been particularly associated with this risk... 
cardiovascular disease | type 2 diabetes | diabetes complications | macrovascular disease | CARDIOMETABOLIC RISK | GLUCOSE CONTROL | PREVENTION | OBESITY | SCREENING TOOL | CARDIO-METABOLIC RISK | DISEASE | ENDOCRINOLOGY & METABOLISM | CIRCUMFERENCE | WEIGHT | ASSOCIATION | Overweight - complications | Diabetic Cardiomyopathies - etiology | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Humans | Middle Aged | Diabetic Angiopathies - etiology | Obesity, Abdominal - physiopathology | Male | Cardiovascular Diseases - complications | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Obesity - mortality | Waist-Hip Ratio | Diabetes Mellitus, Type 2 - complications | Overweight - mortality | Body Mass Index | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Obesity, Abdominal - mortality | Obesity - complications | Mortality | Risk Factors | Diabetic Angiopathies - mortality | Proportional Hazards Models | Obesity - physiopathology | Overweight - physiopathology | Waist Circumference | Obesity, Abdominal - complications | Models, Biological | Diabetes Mellitus, Type 2 - mortality | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Cohort Studies | Diabetics | Usage | Myocardial infarction | Cerebral infarction | Body mass index | Heart attacks | Diabetes mellitus | Death | Diabetes | Cardiovascular diseases | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Hip | Index Medicus | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | cardiovascular disease; diabetes complications; macrovascular disease; type 2 diabetes | Endocrinology and Diabetes
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 1965 - 1971
Aims Type 1 diabetes is associated with an increased risk of cardiovascular disease and all-cause mortality. Numerous studies have demonstrated that outcomes... 
cardiovascular disease | type 1 diabetes | cohort study | dyslipidaemia | GLYCEMIC CONTROL | MELLITUS | TERM | IMPACT | OBESITY PARADOX | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | GENDER | COMPLICATIONS | ASSOCIATION | LIFE EXPECTANCY | Smoking - adverse effects | Prevalence | Age Factors | Diabetic Cardiomyopathies - etiology | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Humans | Middle Aged | Diabetic Angiopathies - etiology | Male | Risk | Scotland - epidemiology | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - therapy | Cardiovascular Diseases - complications | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Adult | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Obesity - mortality | Body Mass Index | Cardiovascular Diseases - etiology | Obesity - complications | Diabetic Angiopathies - mortality | Obesity - physiopathology | Combined Modality Therapy | Diabetes Mellitus, Type 1 - mortality | Diabetic Cardiomyopathies - epidemiology | Obesity - epidemiology | Sex Factors | Survival Analysis | Diabetic Angiopathies - epidemiology | Aged | Cohort Studies | Practice Guidelines as Topic | Hypertension | Medical research | Type 1 diabetes | Mortality | Medicine, Experimental | Heart diseases | Health aspects | Diabetes mellitus | Population studies | Diabetes mellitus (insulin dependent) | Coronary artery disease | Body mass index | Blood pressure | Diabetes | Cardiovascular diseases | Health risk assessment | Smoking | Index Medicus
Journal Article
Atherosclerosis (Supplements) (Component), ISSN 1567-5688, 05/2015, Volume 18, pp. 124 - 133
Diabetes mellitus (DM) is a risk factor for death from heart failure (HF) in patients with dilated cardiomyopathy (DCM) but DM patients are less eligible for... 
Immunoadsorption | β1 receptors | Autoantibodies | Diabetes | Cardiomyopathy | β 1 receptors | HEART | SUBSTITUTION | THERAPY | beta receptors | GUIDELINES | PERIPHERAL VASCULAR DISEASE | BETA-ADRENERGIC RECEPTOR | SOCIETY | Ventricular Function, Left | Diabetic Cardiomyopathies - mortality | Autoantibodies - blood | Humans | Middle Aged | Blood Component Removal - methods | Male | Echocardiography, Doppler, Color | Diabetic Cardiomyopathies - physiopathology | Case-Control Studies | Diabetic Cardiomyopathies - immunology | Recovery of Function | Time Factors | Receptors, Adrenergic, beta-1 - immunology | Adult | Cardiomyopathy, Dilated - diagnosis | Female | Waiting Lists | Diabetic Cardiomyopathies - therapy | Diabetic Cardiomyopathies - blood | Blood Component Removal - adverse effects | Cardiomyopathy, Dilated - mortality | Immunosorbent Techniques - mortality | Cardiomyopathy, Dilated - blood | Risk Factors | Kaplan-Meier Estimate | Heart Transplantation | Treatment Outcome | Biomarkers - blood | Diabetic Cardiomyopathies - diagnosis | Immunosorbent Techniques - adverse effects | Stroke Volume | Disease-Free Survival | Cardiomyopathy, Dilated - physiopathology | Blood Component Removal - mortality | Cardiomyopathy, Dilated - immunology | Exercise Tolerance | Cardiomyopathy, Dilated - therapy | Heart | Transplantation | Cardiomyopathy, Dilated | Risk factors | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 2013, Volume 56, Issue 1, pp. 82 - 91
AIMS/HYPOTHESIS: The aim of this study was to examine the association of physical activity (PA) with all-cause mortality and incident and prevalent... 
All-cause mortality | Exercise | Medicine & Public Health | Human Physiology | Physical activity | Type 1 diabetes | Metabolic Diseases | Internal Medicine | Cardiovascular disease | Epidemiology | STANDARDIZATION | RISK-FACTORS | IDDM COMPLICATIONS | HEMOGLOBIN A1C | PREVENTION | MELLITUS | EUROPE | DENSITY LIPOPROTEIN CHOLESTEROL | ENDOCRINOLOGY & METABOLISM | RETINOPATHY | CONSENSUS STATEMENT | Diabetes Mellitus, Type 1 - epidemiology | Prevalence | Prospective Studies | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Motor Activity | Diabetes Mellitus, Type 1 - therapy | Incidence | Young Adult | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Adult | Diabetic Angiopathies - complications | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Cross-Sectional Studies | Mortality | Diabetic Angiopathies - mortality | Europe - epidemiology | Diabetic Cardiomyopathies - complications | Diabetes Mellitus, Type 1 - mortality | Diabetic Cardiomyopathies - epidemiology | Sex Factors | Diabetic Angiopathies - epidemiology | Longitudinal Studies | Cohort Studies | Complications and side effects | Medical research | Cycling | Health | Analysis | Patient outcomes | Cardiac patients | Medicine, Experimental | Cardiovascular diseases | Index Medicus | consensus statement | density lipoprotein cholesterol | mellitus | retinopathy | risk-factors | iddm complications | standardization | hemoglobin a1c | europe | prevention
Journal Article